Structural decoding of reversible covalent linkage of odorants in human olfactory receptor OR6A2
Cell · 2026
DOI: 10.1016/j.cell.2025.12.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2026. Verfasst von Tian Wang und 16 weiteren Autor:innen. Beteiligte Einrichtung: iHuman Institute, ShanghaiTech University, Shanghai, China; School of Life Science and Technology, ShanghaiTech University, Shanghai, China. Hauptthemen laut MEDLINE: Receptors, Odorant, Odorants. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: Key Technologies Research and Development Program, Canadian Anesthesiologists' Society, National Natural Science Foundation of China.
Abstract (Originalsprache)
Olfactory receptors (ORs) are a diverse superfamily of G protein-coupled receptors responsible for odor detection that are also implicated in non-olfactory physiological functions. OR6A2, a class II OR, selectively senses medium-chain aldehydes and belongs to a cluster of ORs genetically associated with the "soapy" perception of cilantro. It also modulates macrophage-mediated inflammatory responses. Structural studies of ORs have long been challenging. Using a back-mutation strategy, we engineered a functional OR6A2 variant (bmOR6A2) from a consensus OR6 (consOR6). Structures of bmOR6A2 in complex with aldehydes reveal a novel ligand-recognition mechanism involving a reversible Schiff base linkage with residue K4.60, validated by mass spectrometry. By integrating structures of consOR6, molecular dynamics simulations, and functional assays, we identified a conserved D45.51Y6.55Y7.41 triad critical for activation in class II ORs. These findings establish a practical strategy for decoding odorant recognition, offering new insights into olfaction signaling and applications in fragrance and therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- iHuman Institute, ShanghaiTech University, Shanghai, China; School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
- iHuman Institute, ShanghaiTech University, Shanghai, China.
- School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
- iHuman Institute, ShanghaiTech University, Shanghai, China; School of Life Science and Technology, ShanghaiTech University, Shanghai, China. Electronic address: zhaosw@shanghaitech.edu.cn.
- iHuman Institute, ShanghaiTech University, Shanghai, China; School of Life Science and Technology, ShanghaiTech University, Shanghai, China. Electronic address: huatian@shanghaitech.edu.cn.
- iHuman Institute, ShanghaiTech University, Shanghai, China; School of Life Science and Technology, ShanghaiTech University, Shanghai, China. Electronic address: liuzhj@shanghaitech.edu.cn.
Förderung
- Key Technologies Research and Development Program
- Canadian Anesthesiologists' Society
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- ShanghaiTech University
- Shanghai Municipal People's Government
Zitieren
APA
Wang, T., Wu, Y., Wang, L., Li, S., Zhao, F., Wu, L., Liu, Y., Qin, J., Tan, Q., Liu, J., Zeng, L., Chen, Y., Gao, S., Shui, W., Zhao, S., Hua, T., & Liu, Z. J. (2026). Structural decoding of reversible covalent linkage of odorants in human olfactory receptor OR6A2. Cell. https://doi.org/10.1016/j.cell.2025.12.017
Vancouver
Wang T, Wu Y, Wang L, Li S, Zhao F, Wu L, et al. Structural decoding of reversible covalent linkage of odorants in human olfactory receptor OR6A2. Cell. 2026. doi:10.1016/j.cell.2025.12.017
BibTeX
@article{Wang2026,
author = {Wang, Tian and Wu, Yiran and Wang, Ling and Li, Shanshan and Zhao, Fei and Wu, Lijie and Liu, Yue and Qin, Jingzi and Tan, Qiwen and Liu, Junlin and Zeng, Liting and Chen, Yilin and Gao, Shenyuan and Shui, Wenqing and Zhao, Suwen and Hua, Tian and Liu, Zhi-Jie},
title = {Structural decoding of reversible covalent linkage of odorants in human olfactory receptor OR6A2},
journal = {Cell},
year = {2026},
doi = {10.1016/j.cell.2025.12.017}
}
EUVIMED